Working Group Leader – Hermien Kan
New imaging techniques and contrast agents evolve with the development of improved MR technology and need to be tested against established protocols for their added value in the quantitative assessment of muscle pathology.
Specific objectives:
- Hold two expert consensus WG meetings per year to confidentially share pre-clinical and clinical data with the intention to develop joint protocols for new imaging techniques.
- Publish joint reports on experimental validation of new contrasts relevant for the diagnosis and/or assessment of NMD and recommendations for their application by non-experts.
This working group consists of…
| Aristides Bakandritsos | Andrew Blamire |
| Jedrek Burakiewizc | Bruce Damon |
| Paulo de Sousa | Martijn Froeling |
| Melissa Hooijmans | Barbara Janssen |
| Hermien Kan | George Loudos |
| Marisa Garcia Martin | Aart Nederveen |
| Jos Oudeman | Paola Porcari |
| Oliver Scheidegger | Chris Sinclair |
| Gustav Strijkers | John Thornton |